2008 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
2011 (v1)Publication
The presence of recurrent high-risk mutations in cyclin-dependent kinase inhibitor 2A/cyclin-dependent kinase 4 (CDKN2A/CDK4) among melanoma-prone families suggests that a high-throughput, multiplex assay could serve as an effective initial screening tool. To this end, we have developed a multiplex bead-based assay for high-throughput...
Uploaded on: March 27, 2023